Pharmaceutical Customer Relationship Management (PH96)
Developing and Improving CRM
-
CLICK TO DOWNLOAD
- Published 2005
- 277 Pages
- 400+ Metrics
- 210+ Charts and Diagrams
-
Uncover Pharmaceutical CRM strategies, structure, spending and staffing
As the pharmaceutical industry focuses on maximizing the lifetime value of customers and physicians, customer relationship management plays an increasingly important role. This study examines several top companies' CRM strategies and tactics to discover and analyze CRM best practices. From structural involvement to overcoming inherent customer relationship management challenges, this study delves into the topics most relevant to pharmaceutical companies today.
Pharmaceutical Customer Relationship Management analyzes the inner-workings of initiative development, management and improvement processes. The report provides companies with the necessary tools to improve their CRM programs by comparing their spending, staffing, structure, and strategies to those of top pharmaceutical companies.

The report is broken down into four chapters:
Chapter 1: Structure and Resources
- Learn how innovators develop champions for their CRM programs and rely on cross-functional cooperation. Benchmark investment levels and outsourcing strategies of various programs.
Chapter 2: Strategies and Tactics
- Examine top CRM programs- objectives and goals.
- Analyze companies' efforts to measure customer lifetime value and return on investment.
Chapter 3: Challenges and Opportunities
- Uncover some of the top challenges CRM programs face today and learn how to overcome these obstacles.
- Discover how the most successful programs rely on market research to develop customized messages and launch targeted efforts across various media channels.
Chapter 4: Real-World CRM Programs
- Explore 13 real-world CRM programs' resources, structure, development timeframes and media mixes.
- Utilize this study to win additional resource support for your customer relationship management efforts. Apply findings from the study to streamline program management and improvement processes.
-
Companies Included in Pharmaceutical CRM Research
- Ajilon
- ALK-Abello
- Bristol-Myers Squibb
- CPC Healthcare Communications
- Harte-Hanks
- Johnson & Johnson
- Merck
- Novo Nordisk
- Roche
- Sanofi-Aventis
- The Cement Works
- Wyeth
- A pharmaceutical company (name withheld by request)
- Ajilon
-
Pharmaceutical CRM Metrics
The following is a list of metrics included in Pharmaceutical Customer Relationship Management. While this list is not inclusive of all the data in the report, it summarizes the main categories and types of data included in each chapter.
Chapter 1: Structure and Resources
- Management structure of CRM
- Level of CRM operation
- Functions spearheading CRM initiatives
- Functions involved in CRM
- CRM brand-level, therapeutic area-level and corporate-level investments
- Average CRM investments by category
- Budget breakdown by target audience
- Functional contributions to CRM funding
- Headcounts for development, implementation and maintenance stages by category
- Initial CRM investments vs. annual CRM investments by category
- Annual CRM investments vs. desired annual investment by category
- Percentage of implementation investments outsourced
- Percentage of maintenance investments outsourced
- Outsourced activities
- CRM database integration
- Technology investments as a percentage of total CRM investments
Chapter 2: Strategies and Tactics
- Relevancy of CRM objectives
- Applications of CRM programs
- Time to develop and implement CRM programs
- Development phase during which new drugs are integrated into CRM programs
- Pilot programs for CRM
- CRM program measurement
- CRM program results
- CRM program performance ratings
- Measuring customer lifetime value
- Average cost to attain a new patient vs. cost to retain an existing patient
- Average initiative development investments as a percentage of total CRM budget
Chapter 3: Challenges and Opportunities
- Companies' current CRM development stages
- CRM challenges
- Target audiences of CRM initiatives
- Media channels utilized in CRM programs
- Average online marketing investments as a percentage of total marketing investments
Chapter 4: Real-World CRM Programs
There are 13 CRM program profiles in Chapter 4, each of which contains the following metrics and graphics:- Program background information including brand-level, therapeutic area-level, corporate-level CRM initiative, and therapeutic area
- Program overview including target audiences, measuring customer lifetime value, and cost to attain a new patient vs. cost to retain an existing patient
- Program timeframe including current stage of development, development time, and pilot program
- Integration of databases and phase of new drug integration
- Program structure including centralization and operation level
- Functions involved in CRM program and contributions to CRM funding
- Implementation investments broken down by categories and target audiences
- Annual CRM investment vs. desired annual investment and outsourcing budgets and activities
- In-house headcounts at various development stages
- Applications of CRM program and objectives
- Media channels utilized in CRM and online marketing investments as a percentage of total marketing investments
- CRM challenges
- CRM status report including measurement tactics, program results, and performance rating
-
Pharmaceutical CRM Report Sample
The following excerpt is taken from Chapter 1, "CRM Structure and Resources." For an in-depth look at this topic, including data points and analysts' recommendations, please purchase the full report.
Making CRM the Central Marketing Strategy
The first solution to the "problem" of CRM structure may be to eliminate entirely the issue of structure. This happens when CRM is not a separate program but a central tenet of the entire marketing organization. At Company 6, the marketing function oversees the CRM program. The company aims to fit all of its CRM activities into its brands' relationship marketing strategies. For brand teams and the broader marketing organization, customer relationship management is not a discrete program that simply covers data warehousing or add-ons such as direct mail campaigns. Instead, comprehensive relationship management is the dominant paradigm for all marketing teams.
By avoiding the disjointed, uncoordinated efforts, all elements of customer management occur under the broader umbrella of customer relationship management. Patients and physicians move through a process that begins with education and awareness for relevant brands and treatments. Individuals then move through customer acquisition to adherence and, finally, advocacy. The steps are not new, but the marketing organization views customers holistically by understanding their position and progress on the CRM ladder.
Company 6's brands oversee their own CRM. Ultimately, profit and loss responsibility falls to the brand team, which owns all relationship marketing and CRM activity for the brand. Brand heads report into business unit leaders; in the US, each brand tends to fall under the oversight of a vice president of marketing. Other groups that support the brand and work with the CRM system might include marketers focused on healthcare professionals, medical education, consumer marketing and managed care teams.
This excerpt is taken from Chapter 3, "CRM Challenges and Opportunities."
CRM Challenges
As Cutting Edge Information began exploring the topic of CRM, one prevalent challenge emerged. The lack of education and ambiguous definition of what customer relationship management is appeared to be major challenges for many companies. CRM means different things to different people and even to entire organizations. At some companies, CRM is an all-encompassing system that includes all of a brand's marketing efforts, whereas at others, CRM is primarily understood to be a database that gathers information on specific audiences. This great variance in definition even among marketers themselves has left the concept of CRM to the whims of personal interpretation. Unfortunately, this lack of clarity makes it more difficult to achieve success per se, since few boundaries or standards are available to benchmark efforts.
The first step to alleviate this challenge at a company is to determine what CRM means to the organization — including parameters, objectives, tactics and goals. Then it becomes a struggle with internal education so that everyone understands what CRM means, at least from the company's point of view. This education must extend beyond the boundaries of marketing because several other internal functions are involved in the development, support and maintenance of CRM. For a CRM initiative to be successful, cross-functional involvement and cooperation are imperative.
An interviewee from a top pharmaceutical company noted that the inner bureaucracy a team has to deal with to consistently maintain support of the CRM project becomes even more troublesome because of a lack of education. This problem is exacerbated by constant turnover of employees. Oftentimes, new employees will have little knowledge about what CRM is or they may simply not believe in it. This makes it all the more challenging because these functions are responsible for providing content and supporting the CRM program. So the inner-bureaucracy of a company coupled with a lack of education about CRM, makes it an ongoing challenge to maintain support of CRM.
Companies 6 and 9 both identified CRM's lack of clarity as a major obstacle. It is difficult to run a CRM program when CRM is not even clearly defined. On top of that, how do CRM leaders win buy-in from other functions when CRM remains a mystery?
Back to Top







